Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Mylan Institutional, a Viatris Company with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 67457-251-02
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)
- Initial Posting
- 04/10/2020
- Revised Date